The US Federal Drug
Adminsitration (FDA) has
distinguished between different
standards of blood glusose
monitors by creating separate draft
guidances for prescription-use
machines for use in point-of-care
professional health-care settings,
and over-the-counter devices
intended for self-monitoring by
lay-persons.
The FDA seeks specific comments
to the draft documents to refine
the result.
CLICK HERE for details.The above article was sent to subscribers in Pharmacy Daily's issue from 13 Jan 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Jan 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.